Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.


Journal

AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219

Informations de publication

Date de publication:
01 12 2019
Historique:
entrez: 3 12 2019
pubmed: 4 12 2019
medline: 2 10 2020
Statut: ppublish

Résumé

: Suppression of plasma HIV RNA is most often attainable with effective antiretroviral therapy. Despite this, in some individuals, detection of HIV RNA remains evident in the cerebrospinal fluid (CSF) which is generally termed CSF HIV RNA escape. Defining CSF HIV RNA escape from a virological point of view, a symptomatology point of view and its management has many challenges with several different definitions being utilized. In this editorial, we outline proposed consensus definitions of CSF HIV RNA escape with consideration of virological, symptomatology and management aspects of this condition.

Identifiants

pubmed: 31790376
doi: 10.1097/QAD.0000000000002252
pii: 00002030-201912012-00002
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Editorial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

S107-S111

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS094067
Pays : United States

Auteurs

Alan Winston (A)

Section of Infectious Diseases, Imperial College London, London, UK.

Andrea Antinori (A)

National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome.

Paola Cinque (P)

Department of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Howard S Fox (HS)

Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Magnus Gisslen (M)

Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Timothy J Henrich (TJ)

Department of Medicine, University of California, San Francisco, San Francisco.

Scott Letendre (S)

University of California San Diego School of Medicine, Division of Infectious Diseases and Global Public Health, San Diego, California.

Deborah Persaud (D)

Johns Hopkins University School of Medicine & Bloomberg School of Public Health, Baltimore, Maryland.

Richard W Price (RW)

Department of Neurology, University of California, San Francisco, San Francisco, California.

Serena Spudich (S)

Department of Neurology, Yale University, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH